Food News and Research

RSS

New strategies to help allergy sufferers survive the winds of spring, summer

Every spring and summer, millions of Americans dread the trip to the park, the playground, or participating in any of the myriad activities that trigger outdoor allergy symptoms.

8 Apr 2010

Phase III trial of brentuximab vedotin for post-transplant Hodgkin lymphoma initiated

Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.

8 Apr 2010

ICRC will nearly triple aid to combat food shortages, drought in Niger and Mali

The International Committee of the Red Cross announced Tuesday that it plans to increase aid to Niger and Mali, "where several million people are suffering from serious food shortages triggered by drought," SAPA/News24 reports.

8 Apr 2010

Roche NimbleGen to implement GMP for DNA microarrays suite

Roche NimbleGen, announced today a company-wide initiative to implement Good Manufacturing Processes (GMP) for its suite of DNA microarrays. The implementation of GMP will cover the full scope of processes from development through manufacturing and will include all locations. The company plans on achieving GMP compliance followed by subsequent submission for clearance or approval of select array products to the US Food and Drug Administration.

8 Apr 2010

FDA alerts consumers on false and misleading claims about lipodissolve

It's a tempting premise: Get a series of drug injections and see pockets of fat on your body go away for good.

8 Apr 2010

Dubai conference calls for more coordinated approach to global health

Marking the conclusion of the three-day Dubai International Humanitarian Aid and Development (DIHAD) conference Tuesday, conference attendees called for humanitarians to adopt a more coordinated approach to tackling global health needs, the National reports. "Speakers, including health professionals and officials from international organisations, stressed the need to share medical knowledge and innovations during a crisis, citing the recent Haiti earthquake," the newspaper writes.

8 Apr 2010

Clinical testing service for safer dosing of warfarin

Machaon Diagnostics, California's only independent laboratory for testing bleeding and clotting disorders has launched a clinical testing service for patients that have been prescribed warfarin. Warfarin, also known as Coumadin, Jantoven or warfarin sodium, is a potent 'blood thinner' or anticoagulant.

8 Apr 2010

Further delay in the trial of Dr. Jayant Patel

There is yet another delay in the Dr. Jayant Patel manslaughter trial. Justice John Byrne gave the jury a day off on Thursday agreeing to meet on Friday. He parted with encouraging words to the jury saying, "During the Second World War, so I'm told, at times when things were quiet for the soldiers, they were often encouraged with the words of (17th century poet John) Milton from three centuries earlier: `They also serve who only sit and wait'…I mention this because your involvement today now ceases and it will be not necessary for you to be involved in the trial for the rest of the day."

8 Apr 2010

First proton therapy center for New Jersey

Cancer survivors joined representatives from ProCure Treatment Centers, Inc., Princeton Radiation Oncology, and CentraState Healthcare System to break ground on the ProCure Proton Therapy Center in Somerset - the first proton therapy center to be built in the state, located 40 miles from downtown Manhattan.

8 Apr 2010

Nutritional supplement can increase blood circulation of hematopoietic stem cells

A nutritional supplement could stimulate the production of stem cells integral for repairing the body. Research published in BioMed Central's open access Journal of Translational Medicine suggests that a commercially-available supplement can increase the blood circulation of hematopoietic stem cells, which can give rise to all blood cells, and endothelial progenitor cells, which repair damage to blood vessels.

8 Apr 2010

HeartWare's ADVANCE bridge-to-transplant clinical trial: FDA approves additional enrollment under CAP

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll up to an additional 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).

8 Apr 2010

FDA warns false, misleading statements over "lipodissolve" drugs

The U.S. Food and Drug Administration today issued warning letters to six U.S. based medical spas and a company in Brazil for making false or misleading statements on their Web sites about drugs they claim will eliminate fat in a procedure called "lipodissolve," or for otherwise misbranding lipodissolve products.

8 Apr 2010

FDA approves Mylan Pharmaceuticals' generic NuLytely laxative

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution (with Flavor Packs), the generic version of Braintree Laboratories' NuLytely® laxative.

8 Apr 2010

MAP Pharmaceuticals initiates PD trial comparing LEVADEX to IV DHE

MAP Pharmaceuticals, Inc. today announced that the Company initiated a pharmacodynamics (PD) trial to compare the acute effect of LEVADEX™ orally inhaled migraine therapy to intravenous dihydroergotamine mesylate (IV DHE) and placebo on pulmonary artery pressure as measured by echocardiography.

8 Apr 2010

Arizona's hospital industry decides not to push tax to help poor, Maryland health programs struggle financially

"Arizona's hospital industry has decided not to push for an income tax increase on the state's wealthy to help the Arizona Health Care Cost Containment System," the Medicaid program in the state.

8 Apr 2010

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).

8 Apr 2010

Queensland Health pay bungle continues

Either you get overpaid or you don’t get paid at all, that’s how Queensland Health’s casual staff seem to feel. Last week a payroll system which was blamed for overpaying the Queensland Health Staff was replaced with a new one. The new system cost $40 million to develop, but in the opinion of the staff is worse than the old one. A number of them have not been paid at all.

8 Apr 2010

Updated report analyzing approval rates at FDA published

Sagient Research Systems, a leading publisher of independent research for the financial services, institutional investment and corporate intelligence communities, recently published an updated report analyzing approval rates at the U.S Food and Drug Administration. According to its research service, BioMedTracker, the rate of drugs that were approved by the FDA in 2008 and 2009 has remained close to the historical low seen in 2007.

7 Apr 2010

Folate increases risk of breast cancer in women with certain genetic make-up

In most women folate, a type of B vitamin, reduces the risk of breast cancer. However, in women with a certain genetic make-up it has shown to be the opposite: folate raises the risk of breast cancer.

7 Apr 2010

Major social science study to accompany Bovine TB BVDP

A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.

7 Apr 2010